Mikhail Blagosklonny is an oncologist, and one of the best professionals in the area right now.Oncology is the study of treatment of tumors. The prevention, diagnosis, and treatment of cancer is the primary research field of this partition.Mikhail, being one of the most prominent oncologists in the world, is also a philanthropist and a scientist, meaning that, besides being a researcher and professor on oncology, he can also do his other passion, which is to help people in need.Mikhail Blagosklonny is aware of the fact that current cancer treatments are expensive and can only be afforded by rich individuals. Mikhail’s plan for oncology is to develop cancer treatments that would not only be efficient but also inexpensive, and therefore being able to be afforded by everyone regardless of financial status. Cancer is one of the most tragic and deadly diseases in the world, and it is unfortunate that if you are poor, chances are you won’t be able to afford any treatment for it. Mikhail is determined to change that by tirelessly researching ways to cure cancer.
One of the most interesting topics of Mikhail Blagosklonny’s research is the famous Rapamycin. When a person undergoes an organ transplant, the most common danger is that the individual’s body might reject the new organ as it is recognized as a “foreign” substance. The immune system works that way. It targets any foreign substance that goes through our body. Rapamycin is a drug that prevents this kind of “rejection” by the body.Mikhail is conducting research not only on cancer but on aging, and he also considers Rapamycin as a wonder drug, meaning that it has many more utilities than what medicine has found until now. His anti-aging drug is one of the most researched topics on Oncology on the internet, and it is one of the most promising studies in that field that has tremendous potential to change the future.Rapamycin is the primary drug approved for curing Lymphangioleiomyomatosis (LAM). LAM is a very rare lung disease that affects women.
What LAM does is activating the mTOR signaling gateway by infiltrating the lung tissue using Tuberous Sclerosis Complex gene mutations. Lymphangiogenic growth factors are released because of this, but Rapamycin blocks the gateway. Rapamycin is a popular immunosuppressant drug, as explained with the organ rejection trait that it contains. But it is also a popular antiproliferative drug, meaning Rapamycin can help treat cancer in two ways. First, if the cancer patient needs of an organ transplant, Rapamycin is used to make sure that his or her body accepts the new organ. Second, Rapamycin’s antiproliferative properties prevent cancer cells to proliferate in the body, and not only that, but Rapamycin can also boost the body’s immune system in fighting tumors as well as hasten its regression. All of these properties and many others make Rapamycin the world’s best drug that you’ve never heard about, and thanks to the continuous research of Mikhail Blagosklonny, more and more uses for this wonder drug will be discovered.